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Спастицитетот на шаката по мозочен удар ги зголемува тешкотиите на болните во секојдневното 
самозгрижување и ја ограничува ефикасноста на рехабилитацијата. Радијалната екстракорпорална 
терапија со ударни бранови (РЕКТУБ) е предложена како алтернативен третман за редукција на спас-
тицитетот. Целта на истражувањето беше да се евалуираат ефектите од апликација на РЕКТУБ на 
спастична шака по мозочен удар. Материјал и методи: Контролирана клиничка студија во која беа 
вклучени 30 пациенти со спастична шака по мозочен удар, поделени во две групи. Испитуваната гру-
па беше третирана со РЕКТУБ (6 третмани секој втор или трет ден) и стандардна рехабилитациона 
програма. Контролната група беше третирана само со стандарднарехабилитациона програма. За 
клиничка евалуација беа користени Модифицираната Ашфорт Сакала (МАС) и супскорот за моторно 
закрепнување од Фугл-Мајер тестот за процена на сензомоторната функција на горен екстремитет 
и тоа пред третманот, по завршување на 2-та, 6-та и 14-та недела од почетокот на рехабилитацијата. 
Резултати: Средната вредност на оцената на МАС беше значително намалена кај испитуваната група 
веднаш по РЕКТУБ. Кај испитуваната група се забележа значително подобрување на скорот за  мотор-
но закрепнување на Фугл-Мајертестот. Овие резултати се задржаа 12 недели по третманот. Заклучок: 
РЕКТУБ го намали спастицитетот на шаката по мозочен удар и доведе до нејзино подобро моторно 
закрепнување.
Извадок
ЕFFECTS OF RADIAL EXTRACORPOREAL 
SHOCK WAVE THERAPY ON POST-STROKE HAND SPASTICITY
Cvetanka Gjerakaroska Savevska1, Erieta Nikolikj Dimitrova1, Vesna Velic Stefanovska2, Marija 
Gocevska1
1 Institute for Physical Medicine and Rehabilitation, Medical Faculty, Ss. Cyril and Methodius University, Skopje, Republic 
of North Macedonia
2   Institute of Epidemiology and Biostatistics with Medical Informatics, Medical Faculty, Ss. Cyril and Methodius University, 
Skopje, Republic of North Macedonia
Citation: Gjerakaroska Savevska C, Nikolikj Dim-
itrova E, Velic Stefanovska V, Gocevska M. Еffects 
of radial extracorporeal shock wave therapy on 
post-stroke hand spasticity. Arch Pub Health 
2019; 11 (1): 68-76 (Macedonian)
Key words: stroke, spasticity, radial extracorpo-
real shock wave therapy, rehabilitation
*Correspondence: Cvetanka Gjerakaroska 
Savevska, Institute for Physical Medicine and 
Rehabilitation, Medical Faculty, Ss. Cyril and 
Methodius University, Skopje, Republic of North 
Macedonia. Е-mail: cecegerakaroska@yahoo.com
Received: 4-Dec-2018; Revised: 18-Jan-2019    Ac-
cepted: 28-Feb-2019; Published: 15-Mar-2019
Copyright:© 2019. Cvetanka Gjerakaroska Savevs-
ka. This is an open-access article distributed 
under the terms of the Creative Commons Attri-
bution License, which permits unrestricted use, 
distribution, and reproduction in any medium, 
provided the original author(s) and source are 
credited.
Competing Interests: The author have declared 
that no competing interests
Hand spasticity after stroke increases the difficulties of daily living activities and limits the effectiveness 
of rehabilitation. Radial extracorporeal shock wave therapy (RESWT) has been suggested as an alternative 
treatment in spasticity reduction.The aim of the study was to evaluate the effectiveness of RESWT on hand 
spasticity in stroke patients. Material and methods: Controlled clinical trial in which 30patients with post-stroke 
hand spasticity were assigned in two groups. The examined group received RESWT (6 treatments in a period of 
two to three days) along with a standard rehabilitation programme. The control group received only standard 
rehabilitation programme. Clinical evaluations for both groups were performed using the Modified Ashworth 
Scale (MAS) and the subscore for motor recovery of the Fugl–Meyer assessment for the upper extremity at 
baseline, immediately after the second, at 6th and 14th week from the start of the rehabilitation.Results: The 
mean MAS score was significantly decreased inthe examined group after the RESWT.The examined group 
showed a significant improvement according to Fugl-Meyer test score after treatment. These results lasted 
12 weeks after the treatment. Conclusion: RESWT has reduced the hand spasticity and led to a better motor 
outcome of spastic hand after а stroke.
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Introduction
Spasticity after a stroke has a neural com-
ponent (“a motor disorder characterized 
by the velocity-dependent increase in ton-
ic stretch reflexes (muscle tone) with exag-
gerated tendon jerks, which results from 
hyperexcitability of the stretch reflex, as 
one component of the upper motor neu-
ron syndrome disorder”- Lance, 1980) and 
a biomechanical component (an increase 
in the number of myosin bridges between 
the myofilaments - shortening and con-
tractures of the myocytes - Carey and 
Burghardt, 1993).1-4
Within the first 6 weeks after the stroke, 
the prevalence of spasticity is within the 
range from 4% to 27%. The spasticity rate 
was 19% three months after the stroke, 
it was from 21.7% to 42.6% at six months, 
and 17% to 38% after a period of 12 months 
from the stroke. Spastic upper extremity 
was observed in 43% of patients with isch-
emic stroke consequences. In 19%, it was 
affected by a severe degree of spasticity 
(with grade 3 according to the Modified 
Ashworth Scale) compared to 5-6% of the 
lower extremity.2-5 The pathophysiology of 
spasticity is very complex and still not com-
pletely understood. Increased muscle tone 
and tendon reflexes are a result of chang-
es in the equilibrium of input impulses 
from the cortico-reticulo-spinal and other 
descending tracts of the motor and inter-
neuron circuits in the spinal cord, and ab-
sence of an intact corticospinal system.1,5 
The resistance to passive stretching of the 
muscle is not always accompanied by an 
increased stretching reflex, but it is also 
due to changes in the biomechanical prop-
erties of the muscle. This is also supported 
by the electromyographic clinical studies 
which prove that increased muscle tone 
caused by an increased reflex activity 
reaches its maximum within a period of 
1 to 3 months following the stroke. After 
3 months, the possible increase in resis-
tance to passive stretching is due to in-
trinsic changes in the muscles. In patients 
with spasticity, the affected muscles are 
subjected to adaptation, which includes 
formation of a higher percentage of con-
necting bridges (myosin bridges –except for 
those that are separated from the actin fil-
aments during a relaxed muscle state) be-
tween the myofilaments. These rheological 
changes in the muscles lead to shortening 
and possible contractures of the myocytes 
and shortening of the tendons.6-8This is an 
important concept, mostly because the ap-
proaches to treatment of the two “types” 
of hypertonia are different. An increased 
“neural” tone can respond to antispastici-
ty medications or injections of botulinum 
toxin or phenol while a“biomechanical” 
tone will not respond to the abovemen-
tioned. It is best treated with rehabilita-
tion procedures and physical modalities.
A spastic upper extremity after a stroke 
causes difficulties in everyday life, there-
fore it results in hindered feeding, main-
taining hygiene, turning in bed, writing, 
driving a wheelchair. All of these problems 
slowly but surely lead to reduced indepen-
dence and a need to engage another per-
son who will assist the patient with his/
her everyday activities. If left untreated, 
it is accompanied by complications such 
as reduced range of movements, reduced 
postural control, presence of painful 
spasms and contractures, which addition-
ally complicates the condition. Hence, the 
reduction of spasticity in many cases will 
contribute to an improved residual arm 
function.
Radial extracorporeal shock wave ther-
apy (RESWT) involves an application of 
high-intensity acoustic radiation (high-en-
ergy acoustic waves-shock waves). Shock 
waves are defined as the sequence of sin-
gle sound pulses which are characterized 
by high point of pressure that can reach 
up to 100 MPa (1000 Bar), fast reach of this 
pressure within a short period (less than 
10 ns), short duration (10 μs), followed by a 
variable negative pressure that can affect 
cavitation and a frequency of 16-20 Hz.9-12
Over time, it was proven that RESWT is an 
efficient and non-invasive method for the 
treatment of localized musculoskeletal 
pathology including epicondylitis, calcar 
calcanei, plantar fasciitis, disorders of the 
rotator cuff, treatment of trigger points, 
chronic tendinopathy, pseudoarthrosis, 
etc.13-17
Recently, attempts have been made to 
extend the therapeutic range of RESWT, 
thus proving its effectiveness in reducing 
spasticity.18-31
The aim of this study was to evaluate the 
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effects of RESWT in the treatment of post-
stroke hand spasticity as well as its possi-
ble efficacy in motor recovery.
Material and methods
This controlled clinical trial was conduct-
ed in 2018, at the Institute for Physical 
Medicine and Rehabilitation in Skopje, Re-
public of Macedonia. A total of 30 patients 
with post-stroke hand spasticity, who were 
receiving an outpatient or stationary re-
habilitation treatment, were included. All 
participants were fully informed about the 
trial, and each of them signed an informed 
consent form on voluntary participation. 
The study was approved by the Ethics 
Committee of the Medical Faculty, Ss. Cyr-
il and Methodius University in Skopje.
The inclusion criteria were as follows: 
a) age ≥18 and ≤80 years; b) minimum of 
3 months since an ischemic or ahaemor-
rhagic stroke; c) hand and fingers spastici-
ty of the affected limb; d) at least 3 months 
of unchanged dosage of antispasticity 
medications or GABA-ergic medications if 
the patient received such; and e) at least 3 
months of possible use of a passive forearm 
orthosis. The criteria for exclusion from 
the study were: a) not belonging to the age 
group of interest; b) use of anticoagulant 
therapy; c) previous or planned treatment 
with botulinum toxin, phenol, alcohol or 
surgical treatment; d) contracture in the 
hand and fingers of the affected limb; and 
e) Sudeck syndrome/local inflammation at 
the area of application of the treatment.
The participants in the examined group 
(EG) were treated with RESWT and a stan-
dard rehabilitation programme for pa-
tients with hemiplegia/hemiparesis after 
a stroke, while those in the control group 
(CG) were treated only with a standard re-
habilitation programme. The period of re-
habilitation in both groups lasted 4 weeks.
RESWT treatment: The application of 
RESWT was conducted with the device 
BTL-5000 SWT Power Appliance (BTL In-
dustries Ltd., United Kingdom). A total of 
6 (six) treatments were applied every two 
or three days over the spastic muscles ac-
cording to the manufacturer’s recommen-
dations: 1.500 shocks over m.flexor carpi 
radialis and m.flexor carpi ulnaris and 
3.500 shocks on the muscles of the volar 
side of the hand. The applied energy was 
of 2Bars and a frequency of 10Hz. The ap-
plication of the treatment started at the 
beginning of the rehabilitation.
The standard rehabilitation programme 
intended for patients with hemiparesis/
hemiplegia after a stroke consisted of ki-
nesitherapy, manual massage and occupa-
tional therapy.
The overall process of rehabilitation of the 
patients from both groups lasted 4 work-
ing weeks from the start of the rehabili-
tation.
The assessment of the spasticity of the 
wrist and the fingers was performed with 
the Modified Ashworth Scale (MAS). For 
convenience of the statistical analysis, 
MAS grade 1+ was point 2; grades 2, 3, and 
4 were respectively matched to 3, 4, and 5. 
For an assessment of the motor recovery 
of the hand, the subscore for motor recov-
ery of the Fugl–Meyer assessment (FMA) 
for the upper extremity was used.
The clinical findings were evaluated at the 
same time points for the patients from 
both groups: before the start of the reha-
bilitation, immediately after the comple-
tion of the second, sixth and fourteenth 
week of the rehabilitation (i.e. for the ex-
amined group before the RESWT applica-
tion, immediately after the completion of 
the RESWT application, immediately after 
the first and the third month upon com-
pletion of the RESWT application).
Results
The trial covered a total of 30 respon-
dents, of which 23 (76.7%) had ischemic, 
and 7 (23.3%) had a haemorrhagic stroke. 
In the EG, 15 (50%) patients were treat-
ed with RESWTand a standard rehabil-
itation programme, while in the CG 15 
(50%) patients were treated with a stan-
dard rehabilitation programme. Men 
and women were represented in EG as 
(53.3%) vs.7 (46.7%) and in CG as 6 (40%) 
vs. 9 (60%), with no significant associa-
tion between gender and the group that 
the respondents belonged to (Pearson 
Chi-square=0.536, df=1, p=0.464). The av-
erage age of the patients in the examined 
group was 57.53±8.03 [95%CI (53.08-61.98)] 
with a minimum/ maximum age of 45/ 
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69 years. In the control group, the av-
erage age was 60.47±13.67 [95%CI (52.89-
68.04)] with a minimum/ maximum age 
of 19/ 69 years. There was no significant 
age difference between the groups (One 
Way ANOVA: F=0.513; p=0.480).
The average value of the MAS score both in 
EG and in CG was highest at baseline [3.9±1.1 
IQR = 4 (3-5) vs. 3.4±0.9 IQR = 3 (3-4)], and low-
est after 2 weeks of treatment [2.5±1.2 IQR 
= 3 (1-4) vs. 2.8±1.1 IQR = 2 (2-4)]. In each of 
the groups there was a significant difference 
between four measurement times related to 
MAS score values (Fridman test: Chi-Square 
(3)=39.833 p=0.00001) vs. Fridman test: Chi-
Square (3)=21.514 p=0.00001) (Table 1). The 
Post Hoc Test analysis of the values of the 
MAS score, in accordance with the Bonfer-
roni correction, in the EG suggested a signif-
icant difference between baseline/control1; 
baseline/control2 and baseline/control3 
in favor of a significantly higher value at-
baseline(Table 2). In the CG, a significant 
difference in the values of the MAS score 
was observed at baseline/control1; baseline/
control2 and control1/control3 in favor of a 
significantly higher value at baseline vs.con-
trol3.
Table 2.  Post Hoc Test of the values of Modified Ashworth Scale score by groups
Table 1.  Comparison of values of Modified Ashworth Scale score in the four measurement 
  times by groups
Time of 
measurement
No.
(N)
Average
(Mean)
Std. 
Deviation
 Min. Max.
Percentiles
25th 50th 
(Median)
75th
Examined group - Friedman test: Chi-Square (3)=39,833 p=0,00001*
Baseline 15 3.93 1.09 2 5 3 4 5
Control 1 15 2.47 1.25 1 4 1 3 4
Control 2 15 2.60 1.29 1 4 1 3 4
Control 3 15 2.87 1.19 10 4 2 3 4
Control group- Friedman test: Chi-Square (3)=21,514 p=0,00001*
Baseline 15 3.40 0.92 2 5 3 3 4
Control 1 15 2.80 1.11 2 5 2 2 4
Control 2 15 3.00 1.19 2 5 2 2 4
Control 3 15 3.33 1.05 2 5 2 3 4
Wilcoxon 
Signed Ranks 
Test
Baseline/
Control 1
Baseline/
Control 2
Baseline/
Control 3
Control 1/ 
Control 1
Control 1/ 
Control 2
Control 2/ 
Control 3
Examined group
Z
Asymp. Sig. 
(2-tailed)
(3.508)
0.000*
(3.542)
0.000*
(3.771)
0.000*
(1.414)
0.157
(2.449)
0.014
(2.000)
0.046
Control group
Z
Asymp. Sig. 
(2-tailed)
(3.162)
0.002*
(2.646)
0.008*
(1.414)
0.157
(1.732)
0.083
(2.828)
0.005*
(2.236)
0.025
* in accordance with the Bonferroni correctionsignificant for p<0.012
* significant for p<0.05
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Table 4.  Comparison of values of the subscore for motor recovery of FMA for the upper  
  extremity in the four measurement times by groups
Table 3.  Comparison of two groups according to the values of Modified Ashworth Scale 
  score in four times
Time of 
measurement
No.
(N)
Average
(Mean)
Std. 
Deviation
 Min. Max.
Percentiles
25th 50th 
(Median)
75th
 Examined group - Friedman test: Chi-Square (3)=27 p=0.00001*
Baseline 15 12.53 7.14 4 28 7 11 15
2 weeks 15 14.07 7.37 5 30 10 12 15
6 weeks 15 14.11 7.32 5 30 10 12 15
14 weeks 15 14.19 7.27 50 30 10 12 15
Control group- Friedman test: Chi-Square (3)=12.667 p=0.005*
Baseline 15 14.07 6.64 4 30 9 15 18
2 weeks 15 15.20 6.12 8 32 11 15 18
6 weeks 15 14.73 5.94 8 30 10 15 18
14 weeks 15 14.73 5.94 8 30 10 15 18
* significant for p<0.05
The comparison of the MAS score between groups in four measurement times did 
not indicate a significant difference (Table 3).
Mann-Whitney 
U test
Baseline Control1 Control2 Control3
Z
Asymp. Sig. 
(2-tailed)
(1.315)
0.189
(0.708)
0.479
(0.835)
0.404
(0.928)
0.353
a. Group variable: examined / control* significant for p<0.05
The mean value of FMAin the EG was 
lowest at baseline 12.5±7.1 IQR=11 (7-15) 
and highest at 14 weeks of the treatment 
when it was14.2±7.3 IQR=12 (10-15). In 
the CG the value of FMA was lowest at 
baseline, and highest at 2 weeks of the 
treatment for 14.1±6.1 IQR = 15 (9-18) vs. 
15.2±6.1 IQR = 15 (11-18). In each of the two 
groups, we found a significant difference 
between four measurement times 
related to FMA value [Fridman test: Chi-
Square (3)=27 p=0.00001 vs. Fridman test: 
Chi-Square (3)=12.667 p=0.005] (Table 4).
The Post Hoc Test analysis of the subscore 
for motor recovery of the FMA for the 
upper extremityin the EG suggested a 
significant difference between baseline/
control1; baseline/control2 and baseline/
control3 in favor of a significantly higher 
value of the test at control examinations 
(Table 5). In the CG there wasno 
significant difference in the values of the 
subscore for motor recovery between 
the six analyzed combinations of times 
(Table 5). The comparison of the two 
groups in each of the four measurement 
timesrelated to Fugl–Meyer test value 
did not indicate a significant difference 
(p>0.05).
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Discussion
Spasticity itself is not more responsible 
for the functional disability after a stroke 
compared to the other characteristics 
of the central motor neuron syndrome, 
however it is one of the biggest obstacles 
we encounter during the rehabilitation 
process of these patients. A spastic upper 
extremity leads to a poor quality of life. 
It greatly increases the patients’ difficul-
ties during their daily self-care, but it also 
limits the efficiency of physical therapy 
and rehabilitation. It is associated with 
difficult and slow motor recovery of the 
extremity. Therefore, it is assumed that 
the reduction of spasticity in many cases 
will contribute to the improvement of the 
residual function.
Today, there are numerous opportunities 
for spasticity treatment: treatment with 
medications (baclofen, tizanidine, dan-
trolene sodium, diazepam), physical mo-
dalities (ice therapy, magnetotherapy, vi-
bration, EMG biofeedback), rehabilitation 
methods (stretching of spastic muscles, 
active exercises for weak muscles, relax-
ation exercises, coordination exercises, 
limb positioning, Bobath technique, Ka-
bat technique, Brunnstrom method, man-
ual massage), chemodenervation (botu-
linum toxin, phenol, alcohol), surgical 
interventions. However, sometimes even 
with a combination of some of the above-
mentioned methods and the presence of 
side effects of some of them, hypertonia 
reduction can not be achieved.1,2,6 For this 
reason, it is necessary to consider devel-
oping a new non-invasive treatment in 
order to find a solution for this condition.
The results of this study have proven the 
benefits of RESWTin the treatment of 
spastic hand after a stroke. Immediately 
after treatment, there was a reduction in 
the spasticity of the hand and fingers in 
the examined group. The results proved 
that there wasno significant difference 
between the two groups in the individual 
comparison of the MAS score values in 
the four measurement times that may be 
due to the small group of respondents. 
However, in the examined group, a signif-
icant difference was found between the 
average MAS scores in the four measure-
ment times, that is, the highest average 
value of the MAS score at baseline, and 
the lowest was after the completion of 
the treatment. Over time, the therapeu-
tic effect was reduced;still even 3 months 
upon completion of the therapy, there 
was a better clinical result than the one 
before the start of the treatment. In the 
examined group, the mean valueof the 
subscore for motor recovery of the FMA 
for the upper extremity was lowest at-
baseline, and in the other three times it 
was higher, which suggests the possible 
role of RESWTin motor recovery of the 
spastic hand after a stroke.
During and after the treatment, no side 
effects of the application of RESWTwere 
observed. The results of this study con-
firm the benefits of RESWT in reducing 
spasticity and better motor recovery after 
Table 5.  Post Hoc Test of values of the subscore for motor recovery of FMA for the upper 
                              extremityby groups
Wilcoxon 
Signed Ranks 
Test
Baseline/
Control 1
Baseline/
Control 2
Baseline/
Control 3
Control 1/ 
Control 1
Control 1/ 
Control 2
Control 2/ 
Control 3
Examined group
Z
Asymp. Sig. 
(2-tailed)
(2.716)
0.007*
(2.716)
0.007*
(2.716)
0.007*
0.000
1.000
0.000
1.000
0.000
1.000
Control group
Z
Asymp. Sig. 
(2-tailed)
(2.226)
0.026
(1.342)
0.180
(1.342)
0.180
(1.890)
0.059
(1.890)
0.059
0.000
1.000
* in accordance with the Bonferroni correctionsignificant for p<0.012
Vol.11 No.1 2019
74
the treatment. They correspond to the 
results of previous studies that deal with 
this issue, and document the fact that the 
noninvasive RESWTcontributes to a rela-
tively long-lasting reduction in spasticity 
and a better motor recovery of the hand. 
Each of these studies presented a differ-
ent protocol for treatment application.18-31
A unified protocol for the application of 
RESWTin the treatment of spasticity af-
ter a stroke has not been developed, yet. 
The mechanism of action of RESWTon 
spastic muscles isstill not sufficiently fa-
miliar. Different mechanisms of action 
have been proposed, one of the possible 
being reduction in spinal excitability and 
induction of mechanical vibrations.
RESWT can induce synthesis of nitrogen 
monoxide (NO), which plays a role in the 
neuromuscular junctions and is involved 
in neurotransmission, memory forma-
tion, and synaptic plasticity in the central 
nervous system. NO can increase muscle 
and tendon neovascularization, there-
by improving muscle stiffness. NO may 
therefore play an important role in reduc-
ing spasticity and improving muscle stiff-
ness. Also, there are no significant chang-
es in F-wave minimal latency and H-reflex 
latency after ESWT, therefore the effect 
of ESWT on excitability of the spinal cord 
and the Golgi tendon can be excluded as 
the main mechanism.20,21,27 One of the 
possible effects is the direct influence of 
fibrosis and the rheological components 
of the hypertonic muscles. It is consid-
ered that RESWTaffects the structural 
biomechanical properties of the muscle 
in terms of breakdown of persistent rela-
tionships between myofilaments, reduc-
tion of fibrous tissue in the muscle, and 
improvement of inactive connective tis-
sue characteristics.30,31
Conclusion
RESWT reduced spasticity of the wrist 
and hand flexors after a stroke and had 
a positive effect in terms of a better mo-
tor outcome.No side effects of its appli-
cation were observed. RESWT is a safe 
alternative, non-invasive treatment in 
reducing spasticity after a stroke. This 
therapy opens a new field of research in 
the non-invasive treatment of spastic-
ity. Further studies are needed including 
alarge cohort of patients.
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